R

RELX

Global information analytics and decision tools

Inside Account Manager

Full-TimeUpdated on 10/23/2026
$95.3k - $158.8k
Mid
Bachelor's
Dayton, OH, USA
In Person
Sales & Account ManagementAccount Management
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree or equivalent experience is required.
  • Experience in account management, inside sales, customer success, or consultative business-to-business sales is required.
  • Strong consultative selling, relationship management, and customer engagement skills are required.
  • Excellent communication and presentation skills are required to interact effectively with librarians, faculty, researchers, procurement professionals, and institutional leaders.
  • The ability to manage multiple customer relationships and prioritize competing demands in a fast-paced environment is required.
  • Experience using Salesforce or similar customer relationship management platforms to manage pipelines, forecasts, and customer engagement is required.
  • Strong analytical skills are required to interpret customer usage, trends, and business needs to develop strategic recommendations.
  • The ability to negotiate and manage subscription renewals while identifying opportunities for revenue growth is required.
  • The ability to work across cross-functional teams to deliver customer-focused solutions is required.
Responsibilities
  • Manage a portfolio of academic and government accounts, build long-term customer relationships, and serve as the primary inside sales contact.
  • Drive customer retention by managing subscription renewals, identifying risks, and developing strategies to maximize customer value and long-term partnerships.
  • Conduct proactive customer outreach through phone, email, virtual meetings, and digital engagement to strengthen relationships, increase product adoption, and uncover expansion opportunities.
  • Understand institutional priorities, research initiatives, funding environments, and collection development needs to recommend solutions aligned with customer objectives.
  • Identify opportunities to expand Elsevier's portfolio, including journal subscriptions, eBooks, databases, research intelligence solutions, AI-enabled products, and workflow tools.
  • Develop pricing proposals, renewal strategies, and business cases, and negotiate within established pricing and commercial guidelines.
  • Manage the complete sales process from opportunity identification through forecasting, proposal development, contract execution, and post-sale follow-up.
  • Partner with Field Account Managers to execute strategic account plans and coordinate customer engagement across complex accounts.
  • Collaborate with Product Specialists, Customer Consultants, Marketing, and Customer Success teams to deliver customer experiences.
  • Maintain accurate account plans, opportunity pipelines, forecasts, and customer activity within Salesforce and other customer relationship management systems.
  • Monitor market trends, competitive activity, higher education funding, and government research priorities to identify new growth opportunities.
  • Meet or exceed assigned renewal, revenue, and growth objectives while maintaining customer satisfaction.
Desired Qualifications
  • Experience working with academic institutions, libraries, government agencies, research organizations, or other knowledge-based customers is preferred.

About the company

RELX is a global provider of information-based analytics and decision tools for professionals across scientific, technical, medical, legal, risk, business, and exhibitions industries. It operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Its products combine large datasets, analytics, and decision-support tools to help researchers, healthcare professionals, lawyers, and business leaders make informed choices, improve productivity, and achieve better outcomes. Revenue mainly comes from subscriptions, with additional income from transactional sales and advertising. RELX differentiates itself through its deep data assets, specialized industry knowledge, and multi-segment offerings that span content, analytics, and decision-support services. The company pursues a goal of delivering trusted information and insights while supporting corporate responsibility and alignment with the UN SDGs through its products and partnerships.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1894

Get referred to RELX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 revenue grew 7%; Legal grew 10%; Risk grew 8%.
  • February 24, 2026 Lexis+ with Protégé launched globally, expanding AI workflow adoption.
  • September 3, 2026 Doctrine closes, targeting one million European legal professionals.

What critics are saying

  • Anthropic and Thomson Reuters compressed legal AI pricing after February 2026 market shock.
  • Harvey and Legora court law schools in 2026, training future buyer cohorts elsewhere.
  • Exhibitions face Middle East event uncertainty through 2026, threatening margins and calendar-dependent cash flows.

What makes RELX unique

  • LexisNexis’ 200 billion-document corpus still beats generic legal AI models.
  • September 3, 2026 Doctrine acquisition deepens RELX’s European legal AI workflow moat.
  • H1 2026 subscriptions supplied 62% of revenue, stabilizing cash generation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Wellness Program
  • Mental Health Support
  • Family Planning Benefits
  • Health Savings Account/Flexible Spending Account
  • Flexible Work Hours

Company News

Yahoo Finance
Oct 22nd, 2026
RELX reaffirms 2026 outlook as nine-month underlying revenue grows 7%, led by Legal at 10%

RELX, the global provider of information-based analytics and decision tools, reported underlying revenue growth of 7% for the first nine months of 2026. It reaffirmed its full year outlook. Legal grew 10%, Risk 8%, and Scientific, Technical & Medical 6%. Exhibitions rose 4%, held back by disruption in the Middle East. Growth came from AI-enabled analytics and decision tools. RELX's research-grade AI workspace, LeapSpace, is seeing rapid usage growth. RELX expects another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share at constant currency.

Citybiz
Apr 28th, 2026
RELX to Acquire Legaltech Platform Doctrine in European AI Push

RELX Group has entered into an agreement to acquire French legal technology company Doctrine, a move that would expand its... Read More

Business Insider
Mar 1st, 2026
LexisNexis CEO dismisses AI threat as company reports 7% revenue growth

LexisNexis CEO Sean Fitzpatrick has dismissed investor concerns that AI threatens the legal software giant, saying proprietary data gives it a competitive advantage. Shares of parent company Relx fell 14% on 3 February following Anthropic's launch of an AI agent that drafts legal briefs, and are down 17% year-to-date. Fitzpatrick said LexisNexis's database of 200 billion legal documents, including content from Shepard's Citations dating to 1873, cannot be replicated by AI model makers. The company doesn't license its proprietary data to general-purpose AI providers. Relx reported 7% revenue growth for 2025 and 9% increase in adjusted operating profit, driven by customers adopting AI tools. LexisNexis is hiring and hasn't conducted AI-related redundancies.

Yahoo Finance
Feb 22nd, 2026
RELX's LexisNexis launches AI-powered identity management platform for healthcare

LexisNexis Risk Solutions, a wholly owned subsidiary of RELX, has launched a new identity management platform for the healthcare sector. Announced on 19 February, the tool combines identity verification, matching and enrichment capabilities with AI-powered authentication to enhance security throughout patients' healthcare journeys. The platform integrates LexisNexis IDVerse and offers enhanced identity verification, resolution and fraud protection. For healthcare professionals, it accelerates onboarding processes, automates processing and provides digital checks to prevent fraud. RELX is a global information and analytics company serving professional and business customers across scientific, technical, medical, legal and risk management markets.

PR Newswire
Jun 4th, 2025
Elsevier Unveils Rigorous Evaluation Framework To Mitigate Risk In Generative Ai Clinical Decision Support Tools

Clinician-centered framework will be featured in upcoming issue of the Open AccessJournal of the American Medical Informatics Association (JAMIA)Initial evaluations of ClinicalKey AI show high accuracy and usefulness in responses amongst cliniciansNEW YORK, June 4, 2025 /PRNewswire/ -- Elsevier, a global leader in medical information and data analytics, unveiled a groundbreaking evaluation framework for assessing the performance and safety of generative AI-powered clinical reference tools. This innovative approach has been developed for all Elsevier Health generative AI solutions, including ClinicalKey AI, Elsevier's advanced clinical decision support platform, and sets a new standard for responsible AI integration in healthcare. It will be featured in a future issue of the Open Access Journal of the American Medical Informatics Association (JAMIA).The framework, designed with input from clinical subject matter experts across multiple specialties, evaluates AI-generated responses along five critical dimensions: query comprehension, response helpfulness, correctness, completeness, and potential for clinical harm. It serves as a comprehensive assessment to ensure that AI-powered tools not only provide accurate and relevant information but also align with the practical and current needs of healthcare professionals at the point of care.Omry Bigger, President of Clinical Solutions at Elsevier: "This evaluation framework not only supports innovation and advancements to improve patient care but adds an extra layer of review and assessment to ensure physicians are armed with the most accurate information possible. It's a critical step in the implementation of responsible AI for healthcare providers and patients."In a recent evaluation study of ClinicalKey AI, Elsevier worked with a panel of 41-board certified physicians and clinical pharmacists to rigorously test responses generated by the tool for a diverse set of clinical queries. That panel evaluated 426 query-response pairs, and results demonstrated impressive performance, with 94.4% of responses rated as helpful, 95.5% assessed as completely correct, with just 0.47% flagged for potential improvements.Leah Livingston, Director of Generative AI Evaluation for Health Markets at Elsevier, said: "These results reflect not just strong performance, but the real value of bringing clinicians into the evaluation process